1J. Laperra, J. Michaud et J. Masquelier: Etude Pharmacoccinctique des olitgomeres flavanoliques-I I'lates medicinales et phytotherapie, 1977, Tome )XL, p. 1331-142 (in French)

2R. Kuttan, P.V. Donnelly and N. DiFerrante: Collagen treated with (+)-catechin becomes resistant to the action of mammalian collagenase; Experientia 37 (1981). Biekhauser Verlag, Basel. Schweiz.

3Sibbel RP Untersuchungen zu Radikalfiingereigneschaften, Analytik und Herstdllungsverfahren eines Trocknextrak-tes aus der Rinde der Meereskiefer Pinus pinaster Ait. Ph.D. dissertation, Wesffalische Silhelms-Universitiit, Mtlnster, Germany 1996.

4Rohdewald, P. in: FlavonDids in Health and Disease, edited by Rice-Evans, CA, and Packer, L- Marcel Dekker Inc. 1998. p 410.

5Schwitters, J Masquelier: OPC in Practice Alfa Omega Editfice, Rome, Italy, 1995; pp. 56-73. 6Huvnh ITT, Teel RW: Selective induction of apoptosis in human mammary cancer cells (MCF-7) - Anticancer Res 2000 Jul-Aug;20 (4): 2417-20.

7Liveriero L, Pulisis E. Antimutagenic activity of procyanidins from vitis vinifiera. Fitother 1994 65:203-9

8Darienuc JY, Marache P, Choussat H. Resistance Capillaire en Getiatrie Etude d'un Microangioprotecteur. Bordeaux Medical 1980; 1 3:903-7 (in French)

9Delacroix P. Etude en Double Avengle de I'Endotelon dans l'Insuffisance Veineuse Chronique. Therapeutique, la Revue de Medicine 1981-,27-28 Sept: 1 793-802 (in French)

10Thebaut JF, Thebaut P, Vin F. Study of Endotelon in functional manifestations of peripheral venotis insufficiency. Gazettte Medicale 1985;92:96-100

11Corbe C, Boissin JP, Sious A. Light vision and chorioretinal circulation. Studv of the effect of procyanidolic oligomers. JFr. Ophialmol 1988-11:453-60.

12Liu, F, Lau BH, Peng Q, Shah V: Pycnogenoi protects vascular endothelial cells from beta-amvlold induced injury.. Biol Pharm Bull 2000 Jun-23(6):735-7

13Kobayashi MS, Han D, Packer L: Antioxidants and herbal extracts protect HT-4 neuronal cells against glutamate-induced cytotoxicity. Free Radic Res 2000 Feb-,32(2):115-24

14Fitzpatric KDF, Bing B, Rohdewald P. Endothelium-dependent vascular effects of Pycnogenol. J Cardiovasc Phannacol. 1998:32:509-515

15Ptltter M, Grotemeyer KH, Wurthwein G. et al. Inhibition of smoking-induced platelet aggregation by aspirin and Pycnogenol. Thromb Res., 1999 Aug 15-95(4):155-61.

16Blazso G, Gaspar R, Gabor M, et al. ACE inhibition and hypotensive effect of a procyanidins containing extract from the bark- of Pinus pinaster Sol. Pharm Phannacol Lett 1996- 6:8-11. 17Rohdewald, P. in: Flavonoids in Health and Disease, edited by Rice-Evans, CA, and Packer, I,. Marcel Dekker Inc. 1998. p. 416.

18Schmidtke 1, Schoop W. Das hydrostatische Odem und seine medikamentose Beeinflussung. Swiss Med 1984- ' 6:67-69.

19Feine-Haake G. A new therapy for venous diseases with 3,3'4,4'5,7-hexa-dihydro-flavan. Allgemeinmedizin 1975-151:839.

20Ruve H-J. ldentifizierung und Quantifizierung phenolischer Inhaltsstoffe sowie pharmakologischbiochemische Unter-suchungen eines Extraktes aus der Rinde der Meereskiefer Pinus pinaster Alt. Pli.D. dissertation, Westfalische Withelms-Universittit, Mftnster, Germany 1996.

21Cheshier JE, Ardestani-Kaboudanian S, Liang B, et al. Immunomodulation by Pycnogenol in retrovinisinfected or ethanol-fed mice. Life Sci. 1996;5:87-96

22Rohdewald, P. in: Flavon Dids in Health and Disease, edited by Rice-Evans, CA, and Packer, L. Marcel Dekker Inc. 1998. p. 413.

23Rohdewald, P. in: Fliavonoids in Health and Disease, edited by Rice-Evans, CA, and Packer, I,. Marcel Dekker Inc. 1998. pp. 421-436. 2

24Packer L, Rimbach G, Virgili F: Antioxidant activity and biologic properties of a procyanidin rich extract from pine (Pinus maritima) bark, Free Radic Biol Med 1999 Sep;27(5-6):704-24